Comparison of tumour biomarker HER-2/neu (C-erbB-2)
before and after surgery in breast cancer patients

QR Code

Comparison of tumour biomarker HER-2/neu (C-erbB-2) before and after surgery in breast cancer patients

Breast cancer is the most common cancer and a major cause of morbidity and mortality in women worldwide annually. The proto-oncogene Human Epidermal growth factor Receptor-2(HER-2/neu) (C-erbB-2) has been localized to chromosome 17q and encodes a transmembrane tyrosine kinase growth factor recep...

Full description

Bibliographic Details
Main Authors:	Aung, Sanda, Mohd Noor, Noriah, Mohammad Amjad, Nasser, Abdullah, Nasuruddin, Phyu, Htike Myat
Format:	Proceeding Paper
Language:	English English English English
Published:	2014
Subjects:	R Medicine (General) RB Pathology RD Surgery
Online Access:	http://irep.iium.edu.my/39424/ http://irep.iium.edu.my/39424/3/IRIIE_2014-_Book_of_Abstracts.pdf http://irep.iium.edu.my/39424/5/IRIE_2014_B_001.jpg http://irep.iium.edu.my/39424/16/IRIE_2014.pdf http://irep.iium.edu.my/39424/19/IRIE_Abstract_2014.pdf

Similar Items

Detection of Isocitrate Dehydrogenase (IDH-1), Epidermal Growth Factor Receptor (EGFR), P53 and C-erbB2/HER2 mutation in glial tumour
by: Azman, Nusaibah, et al.
Published: (2022)

In silico study of the ErbB4 interactions with curcumin analogs
by: Azman, Putri Arsyadian, et al.
Published: (2015)

Management of ErbB2-positive breast cancer: Insights from preclinical and clinical studies with lapatinib
by: Vogel, C., et al.
Published: (2010)

Detection of Human Papillomavirus, p53 and c-erbB-2 Protein Expression in Juvenile Laryngeal Papillomatosis: A Report of 2 Cases
by: Siti Aishah Md Ali,, et al.
Published: (2006)

Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
by: Chan, Arlene, et al.
Published: (2012)

HER2/neu-based peptide vaccination-pulsed with B-cell epitope induced efficient prophylactic and therapeutic antitumor activities in TUBO breast cancer mice model
by: Nordin, Muhammad Luqman, et al.
Published: (2021)

Human CD3+ T-cells with the anti-ERBB2 chimeric antigen receptor exhibit efficient targeting and induce apoptosis in ERBB2 overexpressing breast cancer cells
by: Munisvaradass, Rusheni, et al.
Published: (2017)

Prevalence of metabolic syndrome and its components among adults in Gebeng, Kuantan (2012)
by: Phyu, Htike Myat
Published: (2013)

Prevalence of metabolic syndrome and its association with physical activity among adults in Kampung Chengal Lempong
by: Phyu, Htike Myat
Published: (2013)

Gender differences on HIV/AIDS related knowledge, attitude and behaviors of attendees at Central Sexually Transmitted Diseases Clinic, Yangon ( 2006 )
by: Phyu, Htike Myat
Published: (2012)

Prevalence of job stress among non-academic staff of International Islamic University Malaysia (IIUM) Kuantan campus
by: Phyu, Htike Myat
Published: (2014)

BCL-2, HER1, HER2, HER3 and HER4 expression in primary colorectal adenocarcinoma
by: Ahmad Zubir, Nurul Mahirah
Published: (2017)

Association between prognostic biomarkers of CyclinD1 and estrogen receptor in breast cancer by immunohistochemical analysis
by: Aung, Sanda, et al.
Published: (2013)

KM-NEU: an efficient hybrid approach for intrusion detection system
by: Lisehroodi, Mazyar Mohammadi, et al.
Published: (2014)

Development of sandwich and label-free electrochemical immunosensor for detection of HER2 breast cancer biomarker
by: Lah, Zur Mira Azizah @ Nor Haiza
Published: (2018)

Expression of c-erbb-2 in upper gastrointestinal tract carcinoma and its associations with metastasis
by: Yunus, Nor Hayati
Published: (2012)

Expression of foxp3 tumour infiltrating lymphocytes in her2 positive breast cancer and their association with clinicopathological features
by: Hashim, Sobry
Published: (2023)

Evaluating the expression of HMGCR in HER2 negative and HER2 positive breast cancer
by: Drahman, Rosmaizan
Published: (2022)

Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen
by: Rusheni Munisvaradass,, et al.
Published: (2017)

Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen
by: Munisvaradass, Rusheni, et al.
Published: (2017)

Comparing neoadjuvant nab-paclitaxel vs paclitaxel both followed by anthracycline regimens in women with ERBB2/ HER2-negative breast cancer-the evaluating treatment with neoadjuvant abraxane (ETNA) trial a randomized phase 3 clinical trial
by: Gianni, L., et al.
Published: (2018)

Expression of HER4 isoforms and HER4 localisation in HER2 negative breast cancer cell lines
by: Ali, Nursyazana Aqilah
Published: (2021)

Cytoplasmic and nuclear HER4 expression in HER2 negative breast cancer cell lines
by: Siti Norasikin Mohd Nafi,, et al.
Published: (2022)

The outcome of breast cancer based on the expression of c-erbb2 , estrogen receptor and progesterone receptor: kelantan experience 2002-2004
by: Mohamed, Moharzudi
Published: (2010)

Deepening democracy in Indonesia? direct elections for local leaders (Pilkada)/ Maribeth Erb, Priyambudi Sulistiyanto
by: Moniruzzaman, Md.
Published: (2009)

Development of complement C5a and its receptor in malignant tumour cells as mammary tumour biomarker
by: Ganti, Norhaifa
Published: (2015)

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer
by: Miles, D., et al.
Published: (2013)

Immunohistochemical studies on the expression of cea, c-erbb-2 and cathepsin din tissue sections and fine needle aspirates of benign breast lesions
by: J, Hasnan, et al.
Published: (2003)

From von Neumann architecture and Atanasoff’s ABC to Neuromorphic Computation and Kasabov’s NeuCube. Part II: Applications
by: Doborjeh, Maryam, et al.
Published: (2018)

Biological characterisation of HER2 amplified breast cancer
by: Barros, Fabrício Félix Tabuada
Published: (2013)

Adjuvant trastuzumab in HER2-positive breast cancer.
by: Slamon, D., et al.
Published: (2011)

Her2 challenge contest: a detailed assessment of automated her2 scoring algorithms in whole slide images of breast cancer tissues
by: Qaiser, Talha, et al.
Published: (2018)

The use of tumour M2-pyruvate kinase as a stool biomarker for detection of colorectal cancer in Hospital Universiti Sains Malaysia
by: Alhadi, Shahidah Che
Published: (2016)

Brain imaging biomarkers in Multiple Sclerosis
by: Altokhis, Amjad
Published: (2023)

The histopathological profile of breast tumours at HTAA
by: Aung, Gyi
Published: (2015)

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
by: Serra, V., et al.
Published: (2011)

Computational pathology and deciphering the complexity of HER2 expression in breast cancer
by: Atallah, Nehal Mohammed
Published: (2025)

Translational control of Human Epidermal Growth Factor Receptors, HER2 and HER4 in response to cellular stresses in breast cancer cells
by: Edwards, Arnelle
Published: (2023)

Her beauty & her terror : portrait of an archetypal land
by: Frantom, Michelle
Published: (2014)

It's her platform
by: Lim, Teik Huat
Published: (2018)